Morphic to Present at TD Cowen 43rd Annual Health Care Conference

Rhea-AI Summary

Morphic Therapeutic (Nasdaq: MORF) announced its participation in the TD Cowen 43rd Annual Health Care Conference, focusing on innovative treatments for gastroenterological diseases. The management team will engage in a GI/Microbiome Panel Discussion at 9:10 AM ET and a Fireside Chat at 11:10 AM ET on March 6, 2023. A live webcast will be accessible on the Investor section of Morphic's website, with an archived replay available afterward. Morphic is dedicated to developing oral integrin therapies for serious chronic diseases, supported by its proprietary MInT technology platform and collaborations with Janssen.

WALTHAM, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that its management team will participate a panel discussion focused on new approached to treat gastroenterological diseases and a corporate fireside chat at the TD Cowen 43rd Annual Health Care Conference.

Presentation Information

GI/Microbiome Panel Discussion
9:10 AM ET, Monday March 6, 2023

Fireside Chat
11:10 AM ET, Monday, March 6, 2023

A live webcast of the presentations will be available on the Investor section of Morphic’s website at www.morphictx.com. An archived replay will be available on the company’s website following the conference.

About Morphic Therapeutic
Morphic Therapeutic is a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. Morphic is also advancing its pipeline and discovery activities in collaborations with Janssen using its proprietary MInT technology platform which leverages the Company’s unique understanding of integrin structure and biology. For more information, visit www.morphictx.com.

Contacts
Morphic Therapeutic
Chris Erdman
chris.erdman@morphictx.com
617.686.1718

FAQ

What is Morphic Therapeutic's participation in the TD Cowen 43rd Annual Health Care Conference?

Morphic Therapeutic will participate in a panel discussion and a fireside chat on March 6, 2023, focusing on new treatments for gastroenterological diseases.

What time will the Morphic Therapeutic panel discussion take place?

The GI/Microbiome Panel Discussion will take place at 9:10 AM ET on March 6, 2023.

When is the fireside chat scheduled for Morphic Therapeutic at the conference?

The Fireside Chat is scheduled for 11:10 AM ET on March 6, 2023.

How can I watch the presentations from Morphic Therapeutic?

You can watch the live webcast of the presentations on the Investor section of Morphic Therapeutic's website.

What does Morphic Therapeutic specialize in?

Morphic Therapeutic specializes in developing oral integrin therapies for serious chronic diseases.